Commentary · 28 Feb 2025
Conference abstractPublished 28 Jun 2022
Effect of vitamin d supplementation on doxorubicin-induced cardiotoxicity in rats
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Doxorubicin, a chemotherapeutic agent, has been widely used in the treatment of solid tumors, bone sarcomas, and cancers of the breast, ovary, and other tumors. Unfortunately, the clinical use of this valuable anticancer drug is limited due to its life-threatening cardiotoxic effect1. Vitamin D is recently known for its cardioprotective effects2. The aim of this study: To investigate role of vitamin D on the doxorubicin-induced cardiac dysfunction. Materials and Methods: 70 female Albino-rats were divided into 4 groups: control group (C); doxorubicin-treated group (Dox): given i.p. injection of 2.5 mg/kg twice per week (cumulative dose:15 mg/kg) over 3 weeks; vitamin D-supplemented group (Vit D): given vitamin D by oral gavage in a dose of 500 IU/kg daily, 5 days a week, also for 3 weeks; and combined Doxorubicin-treated+vitamin Dsupplemented group (Dox+Vit D): rats received the same used doses for the same duration. After 3 weeks, all rats were subjected to EGG recording, determination of plasma levels of brain natriuretic peptide (BNP), cardiac troponin I (cTnI), vitamin D concentration (vit D) and total calcium level (Ca). Hearts were excised and perfused in Langendorff preparation to record intrinsic in vitro activity of the heart under basal conditions according to the technique of Langendorff. Malondialdehyde (MDA), total antioxidant capacity (TAC) and heat shock protein 20 (HSP 20) were assessed in the cardiac tissue. Also, cardiac tissue histopathological studies were performed.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Medicine and Therapeutics.
Opinion · 28 Feb 2025
Integrating Telemedicine into Chronic Disease Management
Short communication · 28 Feb 2025
Emerging Drug Therapies for Resistant Hypertension
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Medicine and Therapeutics
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Faten Mahmoud Ali Diab”
